The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation

dc.contributor.authorPach, Natalie
dc.contributor.authorOchs, Sarah
dc.contributor.authorCao, Jinjing
dc.contributor.authorOttlinger, Julia
dc.contributor.authorAichem, Annette
dc.contributor.authorBasler, Michael
dc.date.accessioned2025-09-05T10:32:04Z
dc.date.available2025-09-05T10:32:04Z
dc.date.issued2025
dc.description.abstractIntroduction: The presentation of pathogen-derived antigens on major histocompatibility complex (MHC) class I is crucial for the antiviral immune response. Degradation of intracellular pathogen-derived proteins by the 26S proteasome generates peptides that can be loaded on MHC-I molecules and presented to cytotoxic T cells. The cytokine-inducible ubiquitin-like modifier (ULM) HLA-F adjacent transcript 10 (FAT10) is encoded in the MHC locus and targets its substrates for proteasomal degradation. Therefore, it acts as an alternative signal for protein degradation, indicating a role in generating the peptide pool for MHC-I presentation. In this study, we aimed to elucidate the role of FAT10 in MHC class I presentation. Methods: Using different human and mouse cell lines deficient for FAT10, the effect of FAT10 on MHC-I surface expression and recovery was studied. For the evaluation of antigen presentation of viral and endogenous epitopes, T cell hybridoma assays and flow cytometry analysis were used. Results: In our study, using model antigens and FAT10-deficient cells, we found that the absence of FAT10 does not affect the abundance of MHC-I molecules or the generation of endogenous and virus-derived MHC-I epitopes. Furthermore, we demonstrated that the cytotoxic T cell response to different viruses remains unchanged in FAT10-deficient mice compared to wild-type mice. Discussion: In summary, our findings indicate that the lack of FAT10 does not impact antigen presentation or the cytotoxic T-cell response across a number of different MHC-I-restricted peptides. Hence, we conclude that the contribution of FAT10 to MHC-I antigen presentation has previously been overestimated.
dc.description.versionpublisheddeu
dc.identifier.doi10.3389/fimmu.2025.1636951
dc.identifier.ppn1935351699
dc.identifier.urihttps://kops.uni-konstanz.de/handle/123456789/74477
dc.language.isoeng
dc.rightsterms-of-use
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/
dc.subjectFAT10
dc.subjectUBD
dc.subjectProteasome
dc.subjectMHC-I
dc.subjectantigen processing
dc.subjectAntigen Presentation
dc.subjectCytotoxic T Cells
dc.subject.ddc570
dc.titleThe ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentationeng
dc.typeJOURNAL_ARTICLE
dspace.entity.typePublication
kops.citation.bibtex
@article{Pach2025ubiqu-74477,
  title={The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation},
  year={2025},
  doi={10.3389/fimmu.2025.1636951},
  volume={16},
  journal={Frontiers in Immunology},
  author={Pach, Natalie and Ochs, Sarah and Cao, Jinjing and Ottlinger, Julia and Aichem, Annette and Basler, Michael},
  note={Article Number: 1636951}
}
kops.citation.iso690PACH, Natalie, Sarah OCHS, Jinjing CAO, Julia OTTLINGER, Annette AICHEM, Michael BASLER, 2025. The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation. In: Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951deu
kops.citation.iso690PACH, Natalie, Sarah OCHS, Jinjing CAO, Julia OTTLINGER, Annette AICHEM, Michael BASLER, 2025. The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation. In: Frontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Available under: doi: 10.3389/fimmu.2025.1636951eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/74477">
    <dc:contributor>Ottlinger, Julia</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Cao, Jinjing</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Ochs, Sarah</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-09-05T10:32:04Z</dcterms:available>
    <dc:language>eng</dc:language>
    <dcterms:abstract>Introduction: The presentation of pathogen-derived antigens on major histocompatibility complex (MHC) class I is crucial for the antiviral immune response. Degradation of intracellular pathogen-derived proteins by the 26S proteasome generates peptides that can be loaded on MHC-I molecules and presented to cytotoxic T cells. The cytokine-inducible ubiquitin-like modifier (ULM) HLA-F adjacent transcript 10 (FAT10) is encoded in the MHC locus and targets its substrates for proteasomal degradation. Therefore, it acts as an alternative signal for protein degradation, indicating a role in generating the peptide pool for MHC-I presentation. In this study, we aimed to elucidate the role of FAT10 in MHC class I presentation. 

Methods: Using different human and mouse cell lines deficient for FAT10, the effect of FAT10 on MHC-I surface expression and recovery was studied. For the evaluation of antigen presentation of viral and endogenous epitopes, T cell hybridoma assays and flow cytometry analysis were used.

Results: In our study, using model antigens and FAT10-deficient cells, we found that the absence of FAT10 does not affect the abundance of MHC-I molecules or the generation of endogenous and virus-derived MHC-I epitopes. Furthermore, we demonstrated that the cytotoxic T cell response to different viruses remains unchanged in FAT10-deficient mice compared to wild-type mice.

Discussion: In summary, our findings indicate that the lack of FAT10 does not impact antigen presentation or the cytotoxic T-cell response across a number of different MHC-I-restricted peptides. Hence, we conclude that the contribution of FAT10 to MHC-I antigen presentation has previously been overestimated.</dcterms:abstract>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/74477"/>
    <dcterms:title>The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation</dcterms:title>
    <dc:contributor>Aichem, Annette</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2025</dcterms:issued>
    <dc:creator>Ochs, Sarah</dc:creator>
    <dc:contributor>Pach, Natalie</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Pach, Natalie</dc:creator>
    <dc:contributor>Basler, Michael</dc:contributor>
    <dc:contributor>Cao, Jinjing</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/74477/1/Pach_2-1707wzlwlltme1.pdf"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-09-05T10:32:04Z</dc:date>
    <dc:creator>Aichem, Annette</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/74477/1/Pach_2-1707wzlwlltme1.pdf"/>
    <dc:creator>Ottlinger, Julia</dc:creator>
    <dc:creator>Basler, Michael</dc:creator>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgold
kops.flag.isPeerReviewedtrue
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-2-1707wzlwlltme1
kops.sourcefieldFrontiers in Immunology. Frontiers. 2025, <b>16</b>, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951deu
kops.sourcefield.plainFrontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Verfügbar unter: doi: 10.3389/fimmu.2025.1636951deu
kops.sourcefield.plainFrontiers in Immunology. Frontiers. 2025, 16, 1636951. eISSN 1664-3224. Available under: doi: 10.3389/fimmu.2025.1636951eng
relation.isAuthorOfPublication9afe818e-2c47-4673-a5d1-0297ae7c8562
relation.isAuthorOfPublication9c11da52-b637-4e3a-9e54-6cbb7e8187e4
relation.isAuthorOfPublicationd9f02c51-17ad-449e-b474-6ebd5cab64da
relation.isAuthorOfPublication330796af-42ba-48a0-90d1-d3b196277661
relation.isAuthorOfPublicationfbcff69e-b4e8-4740-9123-cc2abad5b2af
relation.isAuthorOfPublication.latestForDiscoveryfbcff69e-b4e8-4740-9123-cc2abad5b2af
source.bibliographicInfo.articleNumber1636951
source.bibliographicInfo.volume16
source.identifier.eissn1664-3224
source.periodicalTitleFrontiers in Immunology
source.publisherFrontiers

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
Pach_2-1707wzlwlltme1.pdf
Größe:
2.11 MB
Format:
Adobe Portable Document Format
Pach_2-1707wzlwlltme1.pdf
Pach_2-1707wzlwlltme1.pdfGröße: 2.11 MBDownloads: 24

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
3.96 KB
Format:
Item-specific license agreed upon to submission
Beschreibung:
license.txt
license.txtGröße: 3.96 KBDownloads: 0